Page 88



23ANDME AND YOUR FINANCIAL FUTURE MARTIN LEVY, CLU/RHU Founder & President CorpStrat Woodland Hills, CA

An unintended and growing impact of genetic testing is that insurance products will slim, retract, and perhaps disappear CSA - Levy

Martin Levy, CLU/RHU, is president and founder of CorpStrat, located in Woodland Hills, Calif. The firm comprises of professionals in human resources, executive leadership, insurance, employee benefit design, compensation, and tax and financial planning, and is a leading agency in employee benefits, serving hundreds of companies in Southern California. CorpStrat is one of the largest insurance brokers in the Greater Los Angeles area.

PHONE 818/377.7260 EMAIL WEBSITE ADDRESS 21021 Ventura Blvd., Suite 200 Woodland Hills, CA 91364



The secrets were once buried deep, hidden inside the paired strands of DNA inside every person. The mysteries of the genome—an individual’s complete set of DNA—remained shrouded in 1990, when the Human Genome Project began. A watershed moment came in 2003 when the international research project completed its mission, sequencing the genome. Decoding the blueprint for every human being—what directs their development and influences their health—has provided revolutionary insights ever since. That is why we have seen a significant spike in genetic direct-to-consumer tests from companies like 23andMe. People across the planet are consumed with learning about their genetic family histories. This is a compelling story, now prevalent in movies, books, and television. The story will only get more intriguing. offers risk reports for at least 11 diseases, providing the public with reveal-

ing genetic information. Those who learn about genetic predispositions to disease may be disappointed to find that medicine is lagging behind, but those gaining confidence from learning about the absence of predispositions may find improved confidence about their future. More than 12 million people have taken direct-to-consumer DNA tests, with almost 8 million of those tests occurring since 2016. Recent studies indicate that as much as 15 percent of the U.S. population has taken a genetic test. While advances in medicine, pharmaceuticals, DNA testing, and improved longevity can positively influence our lives, they also pose a significant risk. Protection Strategies

What if you could go back in time and buy Apple or Microsoft stock at issue? What if you could acquire an appreciating asset that you know will not be available in the future, and it could be

Profile for CSQ Magazine

C-Suite Quarterly - New York  

Q1 2019 | Innovation & Technology

C-Suite Quarterly - New York  

Q1 2019 | Innovation & Technology

Profile for csuite